Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Observational Study to Assess Migraine Prediction Tool Based on Prodromal Symptoms and Additional Parameters

NCT05523310 is registered in ClinicalTrials.gov with Theranica as lead sponsor.

NCT NCT05523310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05523310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Observational Study to Assess Migraine Prediction Tool Based on Prodromal Symptoms and Additional Parameters
Lead sponsor
Theranica
Phase
Observational
Overall status
Suspended
Start date
January 1, 2030
Completion date
November 15, 2030
Enrollment
200 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

migraine